**Botulinum Neurotoxins and Nervous System: Future Challenges for Novel Indications**

Editor

**Siro Luvisetto**

MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade • Manchester • Tokyo • Cluj • Tianjin

*Editor* Siro Luvisetto Institute of Biochemistry and Cell Biology (IBBC) National Research Council (CNR) of Italy Italy

*Editorial Office* MDPI St. Alban-Anlage 66 4052 Basel, Switzerland

This is a reprint of articles from the Special Issue published online in the open access journal *Toxins* (ISSN 2072-6651) (available at: https://www.mdpi.com/journal/toxins/special issues/Botulinum Neurotoxins).

For citation purposes, cite each article independently as indicated on the article page online and as indicated below:

LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. *Journal Name* **Year**, *Article Number*, Page Range.

**ISBN 978-3-03943-456-5 (Hbk) ISBN 978-3-03943-457-2 (PDF)**

c 2020 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications.

The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND.

## **Contents**




### **About the Editor**

**Siro Luvisetto** obtained his degree in Chemistry at the University of Padova (Italy). After graduating in 1984, he started his scientific career at the Institute of General Pathology (University of Padova, Italy), where studied mitochondrial physiology with an emphasis on energy conversion during mitochondrial oxidative phosphorylation. In 1987, he was a Visiting Scientist at the Department of Membrane Research of the Weizmann Institute of Science (Rehovot, Israel). In 1988, he obtained a permanent position as a researcher at the National Research Council of Italy (CNR) at the Center for the Study of Mitochondrial Physiology (Padua, Italy). In 1997, he joined the CNR Centre for Biomembranes Study where he changed his research interest toward the biophysics characterization of high-voltage-activated neuronal calcium channels responsible for the familial hemiplegic migraine. In 2001, he moved to Rome where he worked at the CNR Institute of Neuroscience after, then at CNR Institute of Cell Biology and Neurobiology, and, presently, at the CNR Institute of Biochemistry and Cell Biology where he is studying the pharmacology of pain modulation and peripheral nerve regeneration after peripheral nerve injury in animal models. Specifically, his main interest is in the effects of botulinum neurotoxins, serotype A and B, in peripheral regeneration after peripheral nerve injury. Dr. Luvisetto has authored and co-authored more than 90 peer-reviewed journal articles, including reviews and book chapters. He has been an invited speaker at several international and national conferences and meetings. He is an active member of some national and international professional associations. He has served as a reviewer for many scientific journals.

*Editorial*
